Chris Moreau
Chief Executive Officer at ALGERNON PHARMACEUTICALS INC.
Net worth: 93 047 $ as of 2024-04-29
Chris Moreau active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ALGERNON PHARMACEUTICALS INC. | Director/Board Member | 2020-05-12 | - |
| Chief Executive Officer | 2018-02-28 | - | |
| Investor Relations Contact | - | - |
Career history of Chris Moreau
Former positions of Chris Moreau
| Companies | Position | Start | End |
|---|---|---|---|
| QUEBEC PEGMATITE HOLDINGS CORP. | Director/Board Member | 2019-02-07 | 2020-11-25 |
| President | 2019-02-07 | 2019-07-23 | |
Luminor Medical Technologies, Inc.
 Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada. | Director/Board Member | 2011-06-01 | 2016-04-20 |
| Chief Executive Officer | 2007-01-31 | 2016-04-20 | |
| Investor Relations Contact | 2011-03-30 | 2016-04-20 | |
| President | 2007-01-31 | 2016-04-20 | |
Nash Pharmaceuticals, Inc.
 Nash Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nash Pharmaceuticals, Inc. engages in the research and development of repurposed therapeutic drugs and pharmaceutical products. Its focus areas include non-alcoholic steatohepatitis, chronic kidney disease, and inflammatory bowel disease. The company is headquartered in Vancouver, Canada. | Chief Executive Officer | - | - |
| Advansis Capital Corp. | President | - | - |
Statistics
International
| Canada | 5 |
| 2 |
Operational
| Director/Board Member | 3 |
| Chief Executive Officer | 3 |
| President | 3 |
Sectoral
| Commercial Services | 2 |
| Electronic Technology | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 5 |
|---|---|
Luminor Medical Technologies, Inc.
Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada. | Commercial Services |
| Advansis Capital Corp. | |
| Algernon Pharmaceuticals, Inc. | |
First Responder Technologies, Inc.
 First Responder Technologies, Inc. Aerospace & DefenseElectronic Technology First Responder Technologies, Inc. is in the process of exploring business opportunities. The company was founded on January 27, 2017 and is headquartered in Vancouver, Canada. | Electronic Technology |
Nash Pharmaceuticals, Inc.
Nash Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nash Pharmaceuticals, Inc. engages in the research and development of repurposed therapeutic drugs and pharmaceutical products. Its focus areas include non-alcoholic steatohepatitis, chronic kidney disease, and inflammatory bowel disease. The company is headquartered in Vancouver, Canada. | Health Technology |
- Stock Market
- Insiders
- Chris Moreau
- Experience
